1,651.30
-0.35%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Inventurus Knowledge Solutions
Its shares trade on NSE under the ticker IKS.NS. It has been listed since 19 December 2024. In the fiscal year to 31 March 2026, it reported revenue of ₹31.94bn and net income of ₹7.22bn. At that date it held total assets of ₹42.68bn and shareholders' equity of ₹28.00bn.
Inventurus Knowledge Solutions Ltd is a IN-based company operating in Health Care Technology industry. The company is headquartered in Navi Mumbai, Maharashtra. The company went IPO on 2024-12-19. Inventurus Knowledge Solutions Limited is an India-based company. The firm is a technology-enabled healthcare solutions provider and offers a care enablement platform assisting physician enterprises in the United States, Canada and Australia, with a focus on the United States market. The company offers a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Its technology solutions include IKS EVE, Optimix, IKS Stacks, IKS AssuRx, Dashboard, and IKS Scribble. IKS EVE is its multichannel patient access and patient engagement solution. Optimix is its proprietary workflow management platform for revenue optimization. IKS Stacks scans, identifies and abstracts relevant data from incoming clinical documents. In addition, it also uses robotic process automation (RPA) to help automate structured and repetitive processes in virtual desktop/ application environments. Its other platforms include QTranscribe/Medico-Legal, QDocprep, QScribe Assist, and QCode.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 19 Dec 2024
- Employees
- 12,405
- Website
- ikshealth.com ↗
Leadership
Pay as last reported
- Mr. Berjis DesaiNon-Executive Chairman of the Board₹2.7m
- Mr. Sachin GuptaChief Executive Officer, Whole Time Director, since 2006₹8.2m
- Ms. Nithya BalasubramanianChief Financial Officer
- Mr. Sameer ChavanCompliance Officer, Company Secretary₹1.7m
- Mr. Joseph BenardelloAdditional Non-Executive Director, since 2007₹80,000
- Mr. Amit GoelaNon-Executive Nominee Director₹350,000
- Mr. Utpal ShethNon-Executive Nominee Director₹280,000
- Dr. Keith JonesIndependent Director₹2.6m
- Mr. Clarence KingIndependent Director₹3.3m
- Dr. Mary KlotmanIndependent Director₹2.5m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Inventurus Knowledge Solutions Ltd employs 12,405 full-time employees in Health Care Technology.
- The company offers IKS EVE for patient engagement across the United States, Canada, and Australia.
- Inventurus provides Optimix, a proprietary workflow management platform for revenue optimization in healthcare.
Weaknesses
- Inventurus Knowledge Solutions Ltd is headquartered in Navi Mumbai, Maharashtra, India.
- The company went public on 19 December 2024, which may pose initial market challenges.
- Inventurus operates primarily in the United States healthcare market with limited presence in other regions.
Opportunities
- Inventurus can expand its IKS Stacks platform to new healthcare markets in Europe.
- The company has opportunities to grow its RPA solutions for virtual desktop environments in healthcare.
- Inventurus can leverage its QTranscribe platform to enhance transcription services in the United States.
Threats
- Inventurus faces competition from established healthcare technology providers in the United States market.
- The company's reliance on the United States healthcare market could be a risk if market conditions change.
- Inventurus must navigate regulatory changes in the Health Care industry across different countries.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.